Higuchi John W. 4

What Happened
John W. Higuchi, a director of Lipocine Inc. (LPCN), reported an open-market purchase of 123,000 shares on April 6, 2026. The shares were acquired at $2.05 per share for a total reported cost of $252,150. This was a purchase (transaction code P), which is generally viewed as a direct acquisition of stock rather than a sale or derivative transaction.

Key Details

• Transaction date: 2026-04-06; Filing date (Form 4): 2026-04-06. No late filing indicated.
• Trade type: Open market purchase (code P).
• Shares purchased: 123,000 at $2.05 per share; total value $252,150.
• Shares owned after the transaction: Not specified in the reported data.
• Footnotes/plan mentions: None indicated in the filing (no 10b5-1 plan, tax withholding, or cashless exercise noted).

Context
Purchases by directors are direct buys of company stock and can be interpreted by investors as a straightforward buy signal, though filings do not state motivation. This Form 4 shows a routine open-market acquisition by a director; no derivative exercises, gifts, or sales were reported in this filing.